Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

INTRODUCTION: Chronic kidney disease (CKD) has major population health implications, but current imaging approaches provide limited pathophysiological insights. We designed a study to evaluate renal multiparametric magnetic resonance imaging (MRI; mpMRI) as a tool to improve diagnosis, risk stratification, disease monitoring, and therapeutic decision-making in CKD. METHODS: The application of functional renal MRI to improve assessment of CKD (AFiRM study; NCT04238299) is a multicenter, prospective, observational cohort study in people with CKD. Participants underwent renal mpMRI using the harmonized cross-vendor UK Renal Imaging Network: MRI Acquisition and Processing Standardization (UKRIN-MAPS) protocol at baseline and at 2-years. Clinical data are collected annually for 4 years with kidney failure outcomes assessed at 10 years. Primary objectives are to determine associations between MRI measures of kidney morphology, inflammation, fibrosis, perfusion, and oxygenation with CKD progression, and to quantify longitudinal changes in mpMRI measures. A biopsy substudy compares mpMRI measures with histology to explore mechanistic processes including fibrosis. RESULTS: Across 9 centers, 420 participants (biopsy substudy n = 43) completed baseline assessments and mpMRI. Mean age is 55 years (SD 13), and 63.8% are male. Median estimated glomerular filtration rate (eGFR) is 39 ml/min per 1.73 m2 (IQR 29-53), median urine albumin-creatinine ratio (uACR) 47 mg/mmol (IQR 8.3-127.1), and median 5-year Kidney Failure Risk Equation score is 5.6% (IQR 1.0-20.8%). Most common CKD etiologies are IgA nephropathy (22.4%), CKD of unknown etiology (19.5%), and diabetic kidney disease (14.3%). Biopsy substudy participants were demographically similar to the full cohort. CONCLUSION: The AFiRM study has established a representative CKD cohort undergoing advanced renal mpMRI with long-term follow-up. This is an important resource to study how renal MRI measures and their longitudinal changes relate to CKD severity and progression.

More information Original publication

DOI

10.1016/j.ekir.2026.106594

Type

Journal article

Publication Date

2026-08-01T00:00:00+00:00

Volume

11

Keywords

CKD, chronic kidney disease, multiparametric MRI, progression